¼ÓÈëVIP ÉÏ´«¿¼²©×ÊÁÏ ÄúµÄÁ÷Á¿ Ôö¼ÓÁ÷Á¿ ¿¼²©±¨°à ÿÈÕÇ©µ½
   
Ö÷Ìâ : Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)
¼¶±ð: ×ܰæÖ÷
ÏÔʾÓû§ÐÅÏ¢ 
Â¥Ö÷  ·¢±íÓÚ: 2007-01-25   

Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)

Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ XN+~g.0  
'9O4$s1  
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© \^=Wp'5R  
px`o.%`'  
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© (N6 3k1M  
z D&5R/I  
1.Co-stimulators (or co-stimulating molecules) s{I Xth6  
VU~ R  
2.NK-kB +n#kpi'T  
'FVh/};Y.D  
3.Immunoglobulin superfamily '3 B\ I#  
EP!zcp2' C  
4.antigen-presenting cell (APC) rLt`=bl&&U  
?|Q[QP  
5.death domain Jxyeh1z qB  
Z^P]-CB|6A  
6.CCR and CXCR B.:DW3  
T(< [k:`  
7.Lectin (or mitogen) .23z\M8 -  
+f#o ij  
8.Clusters of differentiation, CD) -N'xQ(#n3q  
l| / tKW  
9.B7 family ' KX'{Gy  
PQ}q5?N  
10.Cytotoxic T lymphocyte, CTL) |~QHCg<  
#Y)Gos  
11.IL-15 and IL-15 receptor (IL-15R) `O:ecPD4M  
)s @ }|`  
12.MHC restriction {Q/XV=  
K YSyz)M}  
13.Affinity-chromatography yrp;G_  
v37TDY3;  
14.Cyctosprin A, CsA [&6VI?  
zn5U(>=c  
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) ~;m3i3D  
Equj[yw%@  
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© }sbh|#  
jacp':T  
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 *aE/\b  
9qhX\, h  
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ f-w-K)y$ht  
?CaMn b8  
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹Ô­µÄÌØµã¡£ .@#GNZe  
T d7f  
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© zz4TJ('  
H9@24NFb  
ÃâÒßѧרҵ£º pZpAb+  
>";I3S-t  
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ h92'~X36  
U Bo[iZ|%  
Ïû»¯ÄÚ¿Æ£º qDMVZb-(#  
4Nz@s^9  
2.Ö×Áö¿¹Ô­·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ [Pn(d[$z  
x WZ87  
ѪҺ²¡Ñ§×¨Òµ£º Y|*a,H"_  
|)"`v'8>  
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔ­Òò£¨Ìõ¼þ£©ÊÇʲô£¿
ÆÀ¼ÛÒ»ÏÂÄãä¯ÀÀ´ËÌû×ӵĸÐÊÜ

¾«²Ê

¸Ð¶¯

¸ãЦ

¿ªÐÄ

·ßÅ­

ÎÞÁÄ

¹àË®

  
ÃèÊö
¿ìËٻظ´

ÑéÖ¤ÎÊÌâ:
2+6=? ÕýÈ·´ð°¸:8
°´"Ctrl+Enter"Ö±½ÓÌá½»